The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Macrophages and their products in rheumatoid arthritis
Open accessAbstract
PURPOSE OF REVIEW: Macrophages differentiate from peripheral-blood monocytes. Both monocytes and synovial macrophages are key players in rheumatoid arthritis. These cells are involved in the initiation and perpetuation of inflammation, leukocyte adhesion and migration, matrix degradation and angiogenesis. Macrophages express adhesion molecules, chemokine receptors and other surface antigens. They also secrete a number of chemokines, cytokines, growth factors, proteases and other mediators. RECENT FINDINGS: Macrophage migration-inhibitory factor has drawn significant attention recently. This cytokine is involved in macrophage activation and cytokine production. Migration-inhibitory factor also regulates glucocorticoid sensitivity and may be a pathogenic link between rheumatoid arthritis and atherosclerosis. Novel macrophage-derived chemokines and chemokine receptors have been identified. Interleukin-10 may have several proinflammatory effects that may influence its action in rheumatoid arthritis. Several proteinases including cathepsin G are produced by macrophages during rheumatoid arthritis-associated inflammatory and angiogenic events. Antirheumatic drugs, imatinib, chemokine receptor inhibitors and other specific strategies may become included in the therapy of rheumatoid arthritis. SUMMARY: Macrophages and their products are key players in the pathogenesis of rheumatoid arthritis and may be good therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391
Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
Butcher, E. C. (1991) · Cell · doi:10.1016/0092-8674(91)90279-8 · Cited by 2,761
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Lymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,240
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Adhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584
Hypoxia Regulates Macrophage Functions in Inflammation
Murdoch, C., Muthana, M., & Lewis, C. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6257 · Cited by 455
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 351
Jang, C.-H., Choi, J.-H., Byun, M.-S., & Jue, D.-M. (2006) · Rheumatology · doi:10.1093/rheumatology/kei282 · Cited by 305
Katschke, K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G., Ponath, P., Park, C. C., Pope, R. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1022::aid-anr181>3.0.co;2-n · Cited by 286
Self-citationManzo, A., Paoletti, S., Carulli, M., Blades, M. C., Barone, F., Yanni, G., FitzGerald, O., Bresnihan, B., Caporali, R., Montecucco, C., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425830 · Cited by 251
Chemokines and their receptors in rheumatoid arthritis: Future targets?
Koch, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20932 · Cited by 247
Self-citationFractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis
Ruth, J. H., Volin, M. V., Haines, G. K., Woodruff, D. C., Katschke, K. J., Woods, J. M., Park, C. C., Morel, J. C. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1568::aid-art280>3.0.co;2-1 · Cited by 238
Self-citationOsteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis
Paniagua, R. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28546 · Cited by 220
Haringman, J. J., Kraan, M. C., Smeets, T. J. M., Zwinderman, K. H., & Tak, P. P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.715 · Cited by 217
Selectins: critical mediators of leukocyte recruitment
Patel, K. D., Cuvelier, S. L., & Wiehler, S. (2002) · Seminars in Immunology · doi:10.1006/smim.2001.0344 · Cited by 215
Radstake, T. R. D. J., Sweep, F. C. G. J., Welsing, P., Franke, B., Vermeulen, S. H. H. M., Geurts‐Moespot, A., Calandra, T., Donn, R., & van Riel, P. L. C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21285 · Cited by 209
Cytokines in rheumatoid arthritis.
Ae, K., Sl, K., & Rm, S. (1995) · PubMed · Cited by 169
Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 166
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts
Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K., & Miyasaka, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2046 · Cited by 160
Pathogenic role of the CXCL16–CXCR6 pathway in rheumatoid arthritis
Nanki, T., Shimaoka, T., Hayashida, K., Taniguchi, K., Yonehara, S., & Miyasaka, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21301 · Cited by 155
Szekanecz, Z., & Koch, A. E. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00009 · Cited by 150
Self-citationKorb, A., Tohidast-Akrad, M., Cetin, E., Axmann, R., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22080 · Cited by 138
Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction
Zwerina, J., Hayer, S., Redlich, K., Bobacz, K., Kollias, G., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21626 · Cited by 131
Renner, P., Roger, T., & Calandra, T. (2005) · Clinical Infectious Diseases · doi:10.1086/432009 · Cited by 124
Ruth, J. H., Haas, C. S., Park, C. C., Amin, M. A., Martinez, R. J., Haines, G. K., Shahrara, S., Campbell, P. L., & Koch, A. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21662 · Cited by 111
Self-citationAngiogenesis in rheumatoid arthritis
Zoltán, S. (2005) · Frontiers in bioscience · doi:10.2741/1657 · Cited by 108
Yoo, J. K., Kwon, H., Khil, L.-Y., Zhang, L., Jun, H., & Yoon, J.-W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8280 · Cited by 96
Miranda‐Carús, M., Benito, M., Balsa, A., Cobo‐Ibáñez, T., de Ayala, C. P., Pascual‐Salcedo, D., & Martín-Mola, E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21731 · Cited by 93
Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networksin vivo
Amat, M., Benjamim, C. F., Williams, L., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706912 · Cited by 81
Sunahori, K., Yamamura, M., Yamana, J., Takasugi, K., Kawashima, M., & Makino, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21524 · Cited by 80
Antoniv, T. T., & Ivashkiv, L. B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22055 · Cited by 79
Cytokines in Rheumatoid Arthritis: Potential Targets for Pharmacological Intervention
Szekanecz, Z., Koch, A. E., Kunkel, S. L., & Strieter, R. M. (1998) · Drugs & Aging · doi:10.2165/00002512-199812050-00004 · Cited by 72
Self-citationPákozdi, A., Amin, M. A., Haas, C. S., Martinez, R. J., Haines, G. K., Santos, L. L., Morand, E. F., David, J. R., & Koch, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2021 · Cited by 72
Self-citationRegulation of Mcl‐1 expression in rheumatoid arthritis synovial macrophages
Liu, H., Huang, Q.-Q., Shi, B., Eksarko, P., Temkin, V., & Pope, R. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22132 · Cited by 70
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting
Veale, D. J., & Fearon, U. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.004 · Cited by 68
Ando, W., Hashimoto, J., Nampei, A., Tsuboi, H., Tateishi, K., Ono, T., Nakamura, N., Ochi, T., & Yoshikawa, H. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0684-1 · Cited by 66
Macrophage migration inhibitory factor and glucocorticoid sensitivity
Aeberli, D., Leech, M. T., & Morand, E. F. (2006) · Rheumatology · doi:10.1093/rheumatology/kel142 · Cited by 65
Suzuki, E., & Umezawa, K. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.089 · Cited by 59
Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant
Miyata, J., Tani, K., Sato, K., Otsuka, S., Urata, T., Lkhagvaa, B., Furukawa, C., Sano, N., & Sone, S. (2006) · Rheumatology International · doi:10.1007/s00296-006-0210-8 · Cited by 54
van Lieshout, A. W. T., van der Voort, R., Blanc, L. M. P. L., Roelofs, M. F., Schreurs, B. W., van Riel, P. L. C. M., Adema, G. J., & Radstake, T. R. D. J. (2006) · BMC Immunology · doi:10.1186/1471-2172-7-23 · Cited by 48
Pohlers, D., Huber, R., Ukena, B., & Kinne, R. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21670 · Cited by 47
CCR1 antagonists in clinical development
Pease, J. E., & Horuk, R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.785 · Cited by 44
Jahangier, Z. N., Jacobs, J. W. G., Kraan, M. C., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042333 · Cited by 40
Santos, L. L., & Morand, E. F. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-005-0243-8 · Cited by 38
The Importance of T Cell Interactions with Macrophages in Rheumatoid Cytokine Production
Brennan, F. M., Foey, A., & Feldmann, M. (2006) · Springer eBooks · doi:10.1007/3-540-29714-6_9 · Cited by 31
Takasugi, K., Yamamura, M., Iwahashi, M., Otsuka, F., Yamana, J., Sunahori, K., Kawashima, M., Yamada, M., & Makino, H. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2015 · Cited by 21
Tsuboi, H., Udagawa, N., Hashimoto, J., Yoshikawa, H., Takahashi, N., & Ochi, T. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21425 · Cited by 13
Cited by
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
“Indeed, classically activated macrophages are key mediators of the immunopathology that occurs during several autoimmune diseases, including rheumatoid arthriti”
BackgroundThe pathogenic role of angiogenesis in rheumatoid arthritis
Elshabrawy, H. A., Chen, Z., Volin, M. V., Ravella, S., Virupannavar, S., & Shahrara, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9477-2 · Cited by 533
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
DeNardo, D. G., Andreu, P., & Coussens, L. M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9223-6 · Cited by 515
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007848.pub2 · Cited by 470
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
Metadata
- Authors
- Szekanecz, Z., & Koch, A. E.
- Venue
- Current Opinion in Rheumatology
- Published
- 2007-05
- Volume
- 19
- Issue
- 3
- Pages
- 289-295
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W1967767023
- Cited by
- 308
- References
- 53
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.